NASDAQ-Listed Gibraltar Industries Deepens Cannabis Exposure with Apeks Supercritical Acquisition

In its Q3 earnings release today, building products manufacturer Gibraltar Industries (NASDAQ: ROCK) revealed that it has purchased Ohio-based cannabis extraction equipment company Apeks Supercritical recently. The company, which closed the acquisition in late August, disclosed trailing annual sales through June of $17.7 million, making it a relatively small part of the overall company, which generated sales in the first three quarters of the year of $789 million and expects full-year sales to exceed $1.04 billion.

With Gibraltar’s established portfolio of products and services focused on assisting our customers in designing, building and enhancing their cultivation operations, we recognized our next opportunity to support our customers with optimizing their processing operations.

Bill Bosway, Gibraltar Industries CEO

As a result, we have taken our first step forward with the acquisition of Apeks Supercritical, a company that holds a leading position in extraction processing with a strong leadership team, patented technology, and leading-edge clean extraction technology. We are excited about this market, and will continue to broaden our capabilities, and relevance with our customers.

CEO Bill Bosway, who joined the firm in January, has extended upon a previous initiative to serve the cannabis industry, which has been historically through serving cultivators. His predecessor, Frank Heard, said a year ago on an earnings call “So, we view the cannabis market as much larger than just a greenhouse. And that’s where we’re spending our time to try to figure out where other than the green house side, should we be participating in from an innovative technology perspective. So early days, but I’ve personally sat in a couple of those strategic thinking conferences and done tours of various type of technology companies that we are not involved in today and it’s an exciting space.”

In its investor presentation, the company described “Acquisitions as a Strategic Accelerator” as one of key initiatives, suggesting that this is the primary focus in terms of its capital allocation. The company detailed the strategic rationale for the acquisition

At its investor day this summer just ahead of buying Apeks, it discussed its vetting process for acquisitions. The company suggested it seeks targets with patents, market leadership and strong management that stays in place. No details were provided regarding the acquisition price.

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online communities 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter